SCHEMBL2186548

SCHEMBL2186548

Cc1ccc2[nH]c3c(c2c1)C(C)N(C)C(C)C3

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 4/20 0.54
L3MBTL1 Q9Y468 2/20 0.45
ACHE P22303 4/20 0.41
GRIN1 Q05586 3/20 0.41
GRIN2A Q12879 3/20 0.41
GRIN2D O15399 2/20 0.41
GRIN3B O60391 2/20 0.41
GRIN2B Q13224 2/20 0.41
GRIN2C Q14957 2/20 0.41
GRIN3A Q8TCU5 2/20 0.41
RB1 P06400 3/20 0.41
BAZ2B Q9UIF8 1/20 0.39
ALDH1A1 P00352 3/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GAA P10253 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12480504 0.78 L3MBTL1 (0.53) MCHR1L3MBTL1ACHEGRIN1GRIN2A
SCHEMBL169113 0.75 L3MBTL1 (0.57) MCHR1L3MBTL1ACHEGRIN1GRIN2A
SCHEMBL2813580 0.74 SIGMAR1 (0.68) MCHR1L3MBTL1SIGMAR1
SCHEMBL989134 0.74 SIGMAR1 (0.68) MCHR1L3MBTL1SIGMAR1
SCHEMBL2814208 0.74 SIGMAR1 (0.68) MCHR1L3MBTL1SIGMAR1
SCHEMBL2811337 0.73 SIGMAR1 (0.59) MCHR1L3MBTL1SIGMAR1
SCHEMBL26837002 0.73 L3MBTL1 (0.54) MCHR1L3MBTL1ACHEGRIN1GRIN2A
SCHEMBL2814203 0.70 SIGMAR1 (0.71) MCHR1L3MBTL1RB1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL23828310 0.69 SIGMAR1 (0.69) MCHR1L3MBTL1RB1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL31020951 0.69 SIGMAR1 (0.69) MCHR1L3MBTL1RB1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458155-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC (US) 2016-10-04 US disclosed
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2015-02-19 US disclosed
US-8907097-B2 Pyrido[4,3-b]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
US-8906925-B2 Pyrido[4,3-B]indoles containing rigid moieties MEDIVATION TECHNOLOGIES, INC. (US) 2014-12-09 US disclosed
US-20130190322-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. (US) 2013-07-25 US disclosed
EP-2346332-A1 PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES Medivation Technologies, Inc. (US) 2011-07-27 EP disclosed
US-20100216814-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. 2010-08-26 US disclosed
WO-2010051501-A1 PYRIDO (4,3-B) INDOLES CONTAINING RIGID MOIETIES MEDIVATION TECHNOLOGIES, INC. (US) 2010-05-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150051218-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A MCHR1 409/4885L3MBTL1 2178/4885ACHE 118/4885
US-20130190322-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A MCHR1 409/4885L3MBTL1 2178/4885ACHE 118/4885
US-20100216814-A1 PYRIDO[4,3-B]INDOLES CONTAINING RIGID MOIETIES HTR3B, HTR3D, HTR3A MCHR1 409/4885L3MBTL1 2178/4885ACHE 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.